Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy

Russell H. Wiesner, Richard B. Freeman, David C. Mulligan

Research output: Contribution to journalArticle

213 Citations (Scopus)

Abstract

Recent reports suggest that selected patients undergoing liver transplantation for stage 1-2 hepatocellular cancer (HCC) have an excellent long-term survival and a low incidence of recurrence. In the past, over 45% of HCC patients on the United Network for Organ Sharing/Organ Procurement Transplantation Network waiting list did not receive a donor organ for up to 2 years. This resulted in not only a high mortality rate but a high rate of being removed from the waiting list because of progression of HCC to advanced stages. The introduction of the Model for End-Stage Liver Disease (MELD) allocation policy has had a positive effect on HCC liver transplant candidates with the number of patients transplanted for HCC significantly increasing over the past several years. In addition, waiting time for HCC patients to receive a deceased donor has decreased significantly and the number of patients dropping out from the waiting list because of advanced stage disease has also decreased. An early assessment of the MELD allocation policy suggests that posttransplant survival for HCC patients comparing pre-MELD to post-MELD eras is similar. Using the data we have collected on the MELD allocation policy, we have already made modifications to the MELD allocation policy for HCC patients. It is hoped that through continued data collection and assessment, a consensus can be reached to further optimize the use of deceased donors in HCC recipients.

Original languageEnglish (US)
JournalGastroenterology
Volume127
Issue numberSUPPL.
DOIs
StatePublished - Nov 2004

Fingerprint

End Stage Liver Disease
Liver Neoplasms
Liver Transplantation
Waiting Lists
Tissue Donors
Tissue and Organ Procurement
Survival
Organ Transplantation
Transplants
Recurrence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Liver transplantation for hepatocellular cancer : The impact of the MELD allocation policy. / Wiesner, Russell H.; Freeman, Richard B.; Mulligan, David C.

In: Gastroenterology, Vol. 127, No. SUPPL., 11.2004.

Research output: Contribution to journalArticle

Wiesner, Russell H. ; Freeman, Richard B. ; Mulligan, David C. / Liver transplantation for hepatocellular cancer : The impact of the MELD allocation policy. In: Gastroenterology. 2004 ; Vol. 127, No. SUPPL.
@article{24bb491652584cc9ad8b40515fcf1c0b,
title = "Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy",
abstract = "Recent reports suggest that selected patients undergoing liver transplantation for stage 1-2 hepatocellular cancer (HCC) have an excellent long-term survival and a low incidence of recurrence. In the past, over 45{\%} of HCC patients on the United Network for Organ Sharing/Organ Procurement Transplantation Network waiting list did not receive a donor organ for up to 2 years. This resulted in not only a high mortality rate but a high rate of being removed from the waiting list because of progression of HCC to advanced stages. The introduction of the Model for End-Stage Liver Disease (MELD) allocation policy has had a positive effect on HCC liver transplant candidates with the number of patients transplanted for HCC significantly increasing over the past several years. In addition, waiting time for HCC patients to receive a deceased donor has decreased significantly and the number of patients dropping out from the waiting list because of advanced stage disease has also decreased. An early assessment of the MELD allocation policy suggests that posttransplant survival for HCC patients comparing pre-MELD to post-MELD eras is similar. Using the data we have collected on the MELD allocation policy, we have already made modifications to the MELD allocation policy for HCC patients. It is hoped that through continued data collection and assessment, a consensus can be reached to further optimize the use of deceased donors in HCC recipients.",
author = "Wiesner, {Russell H.} and Freeman, {Richard B.} and Mulligan, {David C.}",
year = "2004",
month = "11",
doi = "10.1053/j.gastro.2004.09.040",
language = "English (US)",
volume = "127",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "SUPPL.",

}

TY - JOUR

T1 - Liver transplantation for hepatocellular cancer

T2 - The impact of the MELD allocation policy

AU - Wiesner, Russell H.

AU - Freeman, Richard B.

AU - Mulligan, David C.

PY - 2004/11

Y1 - 2004/11

N2 - Recent reports suggest that selected patients undergoing liver transplantation for stage 1-2 hepatocellular cancer (HCC) have an excellent long-term survival and a low incidence of recurrence. In the past, over 45% of HCC patients on the United Network for Organ Sharing/Organ Procurement Transplantation Network waiting list did not receive a donor organ for up to 2 years. This resulted in not only a high mortality rate but a high rate of being removed from the waiting list because of progression of HCC to advanced stages. The introduction of the Model for End-Stage Liver Disease (MELD) allocation policy has had a positive effect on HCC liver transplant candidates with the number of patients transplanted for HCC significantly increasing over the past several years. In addition, waiting time for HCC patients to receive a deceased donor has decreased significantly and the number of patients dropping out from the waiting list because of advanced stage disease has also decreased. An early assessment of the MELD allocation policy suggests that posttransplant survival for HCC patients comparing pre-MELD to post-MELD eras is similar. Using the data we have collected on the MELD allocation policy, we have already made modifications to the MELD allocation policy for HCC patients. It is hoped that through continued data collection and assessment, a consensus can be reached to further optimize the use of deceased donors in HCC recipients.

AB - Recent reports suggest that selected patients undergoing liver transplantation for stage 1-2 hepatocellular cancer (HCC) have an excellent long-term survival and a low incidence of recurrence. In the past, over 45% of HCC patients on the United Network for Organ Sharing/Organ Procurement Transplantation Network waiting list did not receive a donor organ for up to 2 years. This resulted in not only a high mortality rate but a high rate of being removed from the waiting list because of progression of HCC to advanced stages. The introduction of the Model for End-Stage Liver Disease (MELD) allocation policy has had a positive effect on HCC liver transplant candidates with the number of patients transplanted for HCC significantly increasing over the past several years. In addition, waiting time for HCC patients to receive a deceased donor has decreased significantly and the number of patients dropping out from the waiting list because of advanced stage disease has also decreased. An early assessment of the MELD allocation policy suggests that posttransplant survival for HCC patients comparing pre-MELD to post-MELD eras is similar. Using the data we have collected on the MELD allocation policy, we have already made modifications to the MELD allocation policy for HCC patients. It is hoped that through continued data collection and assessment, a consensus can be reached to further optimize the use of deceased donors in HCC recipients.

UR - http://www.scopus.com/inward/record.url?scp=7044234929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044234929&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2004.09.040

DO - 10.1053/j.gastro.2004.09.040

M3 - Article

C2 - 15508092

AN - SCOPUS:7044234929

VL - 127

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - SUPPL.

ER -